Vitro Diagnostics Inc. (fka VODG)

[Potse]

StemGenesis...$50M project scheduled for construction......

StemGenesis (www.stemgenesisinc.com) is an US-registered cell therapy technology company. Based in California, the company's business focuses on the market in great China including mainland China, Taiwan and Hong Kong. StemGenesis is involved in two cell therapy-related businesses: medical devices and cell therapy.

According to the last available news article I could find (6/29/2012), StemGenesis is expected to begin construction in Q3 2012 on a two-phase $50M biotechnology project in Qingdao (Shandong Province).

Below are three news articles about the project (in chronological order). They are Google-translated from Chinese, so obviously they are a bit difficult to completely understand. Also, near the end of this post I will include a link to a version of the article that has a picture of the signing ceremony, and I will put the picture at the very end of this post.....

1) October 25, 2011.....

U.S. stem cell project contract settled Qingdao

Limited project signing ceremony was held on October 25 in Qingdao Development Zone Investment Promotion Bureau actively promote investment by American Gan Yuan Biotechnology Co., Ltd. (StemGenesis) Qingdao Bo yuan medical polymer materials. City, China Merchants Development Zone Management Committee leaders attended the signing ceremony.

Investors of the project for the U.S. Gan Yuan Biotechnology Co., Ltd. (StemGenesis), a total investment of $ 50 million. An investment of $ 30 million, $ 10 million of registered capital.

Qingdao Bo yuan medical projects constructed in two phases, one of the main products and the scale of construction is sterile cord blood and umbilical cord collection and processing refrigeration system, including umbilical cord blood collection bag, SCR-1000 stem cells and then integrated tube, CRYOPRO cord blood frozen bags cord blood processing bags AXP special bags, RQ dedicated pipe, stem cells View accessories combination of stem cell products. Two main products and building scale is automatic stem cell separation system and stem cell activating system, including swinging bucket transfected cell separator bag donor cells regulating system, and adipose tissue extraction and processing system, and bone marrow stem cells concentrated system, mononuclear cells regulating device , thrombin concentration system products.

Settled in Qingdao, Qingdao Bo yuan medical material has a very important significance for accelerating the city in the field of stem cell production and R & D to promote the level of health care to improve city life.

http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://www.qdbofcom.gov.cn:8080/zwfb1swyw/52288.htm&prev=/search%3Fq%3D%2522stemgenesis%2522%26hl%3Den%26lr%3Dlang_zh-CN%26safe%3Dimages%26sa%3DX%26tbas%3D0%26biw%3D1008%26bih%3D632%26tbs%3Dlr:lang_1zh-CN%26prmd%3Dimvns&sa=X&ei=BGZRUJK0IuTYyAGqpoD4Bg&ved=0CFwQ7gEwBQ

2) January 17, 2012......

Bo yuan of medical materials, Qingdao Development Zone project is progressing well

Changjiang Road neighborhood offices to discuss the introduction of Qingdao Bo Yuan the dry source Biotechnology Co., Ltd. invested and established medical material items, the signing has been settled since October 25, 2011, under the joint efforts of all parties, in January this year, 6 May the successful completion of the procedures for bidding, auction and 31 acres of land use rights, a bio-pharmaceutical projects the international ecological wisdom of the city first settled.

Gan Yuan Biotechnology Co., Ltd., headquartered in California, the company consolidated the Harvard University stem cell research and the world's most advanced stem cell bank built tube experience. Engaged in biological stem cell research, stem cell library construction and management of a new generation of sterile cord blood and cord blood collection system, and automatically stem cell separation system and stem cell activation system, the production of high-tech enterprises.

The project is located in the City of ecological wisdom, planning area of ??31 acres, a total investment of 50 million U.S. dollars, plans constructed in two phases. An investment of $ 20 million, is mainly engaged in the polymer biomedical materials products, including collecting medical equipment, medical collection containers and other products of research and development, marketing and consulting. Qingdao Bo yuan medical materials project, our country involved in the field of high-tech projects, and its successful introduction, the introduction of the corresponding medical high-tech talent to accelerate our region's pace, driven by the rapid development of related industries.

http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://www.parkchina.net/2012/0117/43964.html&prev=/search%3Fq%3D%2522%25E7%25BE%258E%25E5%259B%25BD%25E7%2594%2598%25E6%25BA%2590%25E7%2594%259F%25E7%2589%25A9%25E7%25A7%2591%25E6%258A%2580%25E6%259C%2589%25E9%2599%2590%25E5%2585%25AC%25E5%258F%25B8%2522%26hl%3Den%26lr%3Dlang_zh-CN%26safe%3Dimages%26biw%3D1008%26bih%3D632%26tbs%3Dlr:lang_1zh-CN%26prmd%3Dimvns&sa=X&ei=7NJQUKoLyrnLAcW7gIgB&ved=0CHMQ7gEwBg

3) June 29, 2012.....

Qingdao Bo Yuan Medical Technology Co., Ltd. (Qingdao) project

Investment in the project is the United States Gan Yuan Biotechnology Co., Ltd., plans a total investment of $ 50 million, a total investment of $ 20 million, the registered capital of $ 10 million, is located in a small west side of Jiangshan Road, Fuchun River Road north, accounting for land 31 acres. The project plans to build a biotechnology industrial park, the main building with an annual output of 90,000 units of cord blood collection bags and 50,005 thousand units of umbilical cord blood processing bag workshop and supporting facilities, the main building consists of the assembly machine shop, mixing tank workshop, sterilization, is a workshop, office buildings, laboratories, warehouses and other.

The project put into production that year, expected operating income of $ 9.932 million (62.57 million yuan), the profit amounted to $ 1,422,500 (8.96 million yuan). The normal average annual operating income (excluding tax) $ 23,249,900, an average annual tax amount of 23.16 million yuan. Total investment rate of return of 17.38%, net profit margin of 13.04% of capital, the project is expected to be 30% annual increments.

Investment in Active-the Gan source biotechnology Co., Ltd. is a high-tech company, registered in the United States has the world's advanced technology and management team, the company combines the experience of Harvard University stem cell research and the world's most advanced stem cell library developed a The new generation of sterile cord blood and umbilical cord collection system, automatic stem cell separation system and stem cell activation system results. The project will work with our university and renowned academician cooperation, the project will generate huge driving effect the introduction of high-tech talent in our region.

Progress: This project is doing the planning and design plans to start the construction of the third quarter of this year.

http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://www.qda.gov.cn/Get/zdqy/1206291118442154.htm&prev=/search%3Fq%3D%2522%25E7%25BE%258E%25E5%259B%25BD%25E7%2594%2598%25E6%25BA%2590%25E7%2594%259F%25E7%2589%25A9%25E7%25A7%2591%25E6%258A%2580%25E6%259C%2589%25E9%2599%2590%25E5%2585%25AC%25E5%258F%25B8%2522%26hl%3Den%26lr%3Dlang_zh-CN%26safe%3Dimages%26biw%3D1008%26bih%3D632%26tbs%3Dlr:lang_1zh-CN%26prmd%3Dimvns&sa=X&ei=7NJQUKoLyrnLAcW7gIgB&ved=0CEUQ7gEwAQ

Link to the article with a picture from the signing ceremony.....

http://translate.google.com/translate?hl=en&sl=zh-CN&u=http://www.hdxxg.com/html/2011/1026/1952451835.htm&prev=/search%3Fq%3D%2522%25E7%25BE%258E%25E5%259B%25BD%25E7%2594%2598%25E6%25BA%2590%25E7%2594%259F%25E7%2589%25A9%25E7%25A7%2591%25E6%258A%2580%25E6%259C%2589%25E9%2599%2590%25E5%2585%25AC%25E5%258F%25B8%2522%26start%3D10%26hl%3Den%26safe%3Doff%26sa%3DN%26biw%3D1008%26bih%3D632%26prmd%3Dimvns&sa=X&ei=FW9RUJf-IKOXyAHL2YC4Bw&ved=0CCMQ7gEwADgK